Article

COVID-19: How Orbis International is managing operations

Author(s):

Alex Delaney-Gesing

Danny Haddad, MD, chief of program at Orbis International, shares an update on how the company's operations have shifted during the coronavirus pandemic, as well as the record-breaking impact on one of its telehealth platforms.
 


See more coronavirus coverage here

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Early monoclonal antibody treatment of COVID-19 beneficial for high-risk COVID-19 patients
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
Related Content
Astigmatism in Hong Kong children increased substantially following COVID-19–era restrictions
May 20th 2025

Astigmatism in Hong Kong children increased substantially following COVID-19–era restrictions

Reflecting on life during a pandemnic
June 14th 2021

Reflecting on life during a pandemnic

How COVID-19 shifted ophthalmologist-patient communication
March 21st 2025

How COVID-19 shifted ophthalmologist-patient communication

Adjusting ophthalmology practice to a pandemic
April 19th 2021

Adjusting ophthalmology practice to a pandemic

Study finds COVID-19 led to significant decline in common eye surgeries
February 9th 2025

Study finds COVID-19 led to significant decline in common eye surgeries

Researchers investigate how COVID-19 affects retinal microvascular structure
February 5th 2025

Researchers investigate how COVID-19 affects retinal microvascular structure

© 2025 MJH Life Sciences

All rights reserved.